Daily Self-Weighing for Obesity
Trial Summary
Do I have to stop taking my current medications for this trial?
The trial protocol does not specify whether you need to stop taking your current medications.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the idea that Daily Self-Weighing for Obesity is an effective treatment?
The available research shows that daily self-weighing can be an effective treatment for obesity. One study found that people who weighed themselves daily and used a supportive program lost more weight than those who did not. Another study showed that young women who weighed themselves daily had significant declines in body weight and body fat over two years. Additionally, a study using a commercial app found that people who consistently tracked their weight lost more weight than those who did not. These findings suggest that daily self-weighing can help people lose weight and prevent weight gain.12345
What data supports the effectiveness of the treatment Daily Self-Weighing for Obesity?
What safety data exists for daily self-weighing in obesity treatment?
The literature suggests that daily self-weighing is generally safe and effective for weight control, with recent studies showing it can aid in weight loss and prevent weight gain. While early research raised concerns about potential negative psychological effects, more recent trials have not confirmed these concerns. However, more research is needed to understand the role of feedback and individual differences in response to self-weighing.13678
Is daily self-weighing safe for humans?
Is daily self-weighing a promising treatment for obesity?
How does daily self-weighing differ from other treatments for obesity?
Daily self-weighing is unique because it involves individuals regularly monitoring their weight, which can help with weight loss and maintenance by increasing awareness and motivation. Unlike other treatments that may involve medication or structured diet plans, this approach focuses on self-monitoring and behavioral change.1391011
What is the purpose of this trial?
99 patients age 12 to \<18 years old with obesity (BMI \>/=95th percentile), will be randomized to one of three treatment interventions:1. Usual Care2. Usual Care plus advice to weigh daily on simple scale3. Usual Care plus advice to weigh-daily on an EHR-connected scaleSurvey data collected at baseline, 2, 4, 6, and 12-weeks, and qualitative interviews at 12 weeks, will assess acceptability, safety, self-efficacy, and BMI. Recruitment will also be assessed (% eligible patients who consent). In order to understand real-world feasibility of this intervention, the clinic staff will work with patients to connect the scales to Epic.
Research Team
Carolyn Bramante, MD
Principal Investigator
University of Minnesota
Eligibility Criteria
This trial is for adolescents aged 12 to under 18 who are dealing with obesity, defined as having a BMI at or above the 95th percentile. It's not clear what conditions exclude someone from participating.Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants are randomized to one of three interventions: Usual Care, Usual Care plus advice to weigh daily on a simple scale, or Usual Care plus advice to weigh daily on an EHR-connected scale. Survey data collected at baseline, 2, 4, 6, and 12 weeks.
Follow-up
Participants are monitored for safety and effectiveness after treatment, including qualitative interviews at 12 weeks to assess acceptability, safety, self-efficacy, and BMI.
Treatment Details
Interventions
- Self-Weighing
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Minnesota
Lead Sponsor